Cost-effectiveness of lapatinib plus capecitabine in women...

Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab

Thomas E. Delea, Paul Tappenden, Oleg Sofrygin, Dominy Browning, Mayur M. Amonkar, Jon Karnon, Mel D. Walker and David Cameron
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
The European Journal of Health Economics
DOI:
10.2307/23275635
Date:
October, 2012
File:
PDF, 2.24 MB
english, 2012
Conversion to is in progress
Conversion to is failed